BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38018068)

  • 1. [Efficacy and safety of endoscopic submucosal dissection with additional radiotherapy for T1a-MM/T1b-SM esophageal squamous cell carcinoma].
    Chen YF; Liu SQ; Li MY; Chen R; Shi RH
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3676-3682. PubMed ID: 38018068
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
    Lu H; Bei Y; Wang C; Deng X; Hu Q; Guo W; Zhang X
    PLoS One; 2024; 19(2):e0298792. PubMed ID: 38386660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial.
    Zhang Y; Liu L; Wang Q; Guo L; Ye L; Zeng H; Zeng X; Yuan X; Li Y; Zhang Y; Zhou E; Hu B
    Endoscopy; 2020 Dec; 52(12):1066-1074. PubMed ID: 32668474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Submucosal Dissection Versus Radical Surgery for T1 Superficial Esophageal Cell Carcinoma: a Subgroup Survival Analysis.
    Liu X; Guan HY; Zhu Q; Tang C; Cheng F; Zeng C; Chen Y
    J Gastrointest Cancer; 2023 Mar; 54(1):155-164. PubMed ID: 35192141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
    Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
    Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
    Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
    Yang X; Zhao L; Shi A; Chen C; Cao J; Zhang Y; Zhu H; Wang J; Zhou W; Li X; Hu S; Men Y; Wang J; Xue L; Liu Y; Dou L; Zhang Y; Sun S; Yuan M; Bao Y; Ma Z; Liu Y; Zhang W; Bi N; Wang G; Hui Z
    Am J Gastroenterol; 2023 Aug; 118(8):1344-1352. PubMed ID: 36972240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic Submucosal Dissection Versus Surgery for Superficial Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Survival Analysis.
    Lee HD; Chung H; Kwak Y; Choi J; Lee A; Kim JL; Cho SJ; Kim SG
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00193. PubMed ID: 32675704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma with Relative Indications.
    Liu Y; Qian D; Tang B; Fan C; Yu J; Lin H; Bai J; Zhao X
    Dig Surg; 2021; 38(1):14-23. PubMed ID: 33271540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection.
    Shimada T; Hatta W; Takahashi S; Koike T; Ohira T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Nakamura J; Matsumoto T; Iijima K; Fukuda S; Masamune A; Ito K;
    Dig Endosc; 2022 Nov; 34(7):1382-1391. PubMed ID: 35702926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat endoscopic submucosal dissection as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial endoscopic submucosal dissection.
    Xu JQ; Zhang ZC; Chen WF; Xu MD; Chen SY; Zhong YS; Zhang YQ; Hu JW; Cai MY; Yao LQ; Zhou PH; Li QL
    Gastrointest Endosc; 2022 Jul; 96(1):18-27.e1. PubMed ID: 35240119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma: a propensity score matching analysis.
    Huang R; Cai H; Zhao X; Lu X; Liu M; Lv W; Liu Z; Wu K; Han Y
    Gastrointest Endosc; 2017 Nov; 86(5):831-838. PubMed ID: 28286094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of deep invasive submucosal colorectal cancer after ESD.
    Watanabe D; Toyonaga T; Ooi M; Yoshizaki T; Ohara Y; Tanaka S; Kawara F; Ishida T; Morita Y; Umegaki E; Matsuda T; Sumi Y; Nishio M; Yokozaki H; Azuma T
    Surg Endosc; 2018 Apr; 32(4):2123-2130. PubMed ID: 29098429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study.
    Joo DC; Kim GH; Park DY; Jhi JH; Song GA
    Gut Liver; 2014 Nov; 8(6):612-8. PubMed ID: 25368748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.